ANGLE PLC (AGL)
Industry Diagnostics & Research
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
9.00p
Buy
10.00p
-0.25p (-2.56%)
Prices updated at 13 Nov 2024, 17:05 GMT
| Prices minimum 15 mins delay
Prices in GBX
ANGLE PLC is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company's product includes Parsortix cell separation system.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2022 | 2023 |
|---|---|---|
| 1m | 2m | |
| 613,000 | 2m | |
| -26m | -20m | |
| -2,508.07 | -935.86 | |
| -22m | -20m | |
| -21m | -19m | |
| Sales, General and administrative | 557,000 | 382,000 |
| Interest expenses | 354,000 | 325,000 |
| Provision for income taxes | -3m | -1m |
| Operating expenses | 27m | 22m |
| Income before taxes | -24m | -22m |
| Net income available to common shareholders | -22m | -20m |
| -0.087758 | -0.077175 | |
| Net interest income | -218,000 | 138,000 |
| Advertising and promotion | - | - |
| Net investment income, net | 2m | -1m |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -0.087758 | -0.077175 |
| Free cash flow per share | -0.0827 | -0.0627 |
| Book value/share | 0.1221 | 0.1229 |
| Debt equity ratio | 0.108304 | 0.170234 |
Balance sheet
Year | 2022 | 2023 |
|---|---|---|
| Current assets | 39m | 21m |
| Current liabilities | 5m | 4m |
| Total capital | 40m | 23m |
| Total debt | 5m | 5m |
| Total equity | 40m | 23m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 50m | 31m |
| Total liabilities | - | - |
| Cash and cash equivalents | 32m | 16m |
| Common stock | 261m | 261m |
Cash flow
Year | 2022 | 2023 |
|---|---|---|
| Cash at beginning of period | 32m | 32m |
| Cash dividends paid | - | - |
| -18m | -15m | |
| Investments (gains) losses | -2m | -203,000 |
| 32m | 16m | |
| Net income | - | - |
| -16m | -14m | |
| -2m | -660,000 |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
